With local regulatory regimes making the transition to global reporting standards, we shared our thoughts on how the industry can adapt by planning ahead to ensure efficient capital management. This article was first published in the Asia Insurance Review, March 2017 issue.
With uncertainty still amounting after the Brexit vote, we wanted to take a look at the legislative impact (including Solvency II) on insurers given the extent of EU law in the insurance sector. This paper discusses these potential impacts and how other changes, such as Passporting and The Great Repeal Bill might impact the UK insurance market.
In this article, Deepak Gandhi and Rakesh Kaul discuss how the emergence of new technology has the potential to change the way we underwrite our customers, distribute insurance products, collect data, and change consumer behaviour in the actual buying of insurance products.
In this presentation, Darshan shares his views on innovation models which can spark innovation in everyone. In this interactive session, the audience brainstormed, crowd sourced, voted and overcame pain points in the insurance industry through innovation.
In this presentation, Darshan shares his views on the life, health and longevity insurance needs of the 'Silver Market' in Asia and how these can be met with innovation from the industry.
This presentation details the findings from our Terminal Illness study, including the survival experience of terminal illness claimants, the impact of terminal illness on the cost of cover and the survival patterns by cause of terminal illness. The presentation also explores practical claim management and how we can improve terminal illness cover going forward.
A presentation on the common models of automated underwriting systems and the must-have features of an expert underwriting system; detailing the key functionality of UnderwriteMe.
Looking at the UK protection market from a global perspective and analysing the challenges, trends and opportunities we face. The presentation also looks at lessons we can learn from other markets, particularly Australia.
A presentation on the pension developments in global markets, including the US, also looking at the implications for advisers in recommending longevity annuities and the risk considerations that would drive the appetite and pricing of providers.
A short analysis of cancer products around the world and how they compare against wider health protection. This presentation also explores a possible blueprint for a UK product and the technical issues in designing and pricing such a product.